A longitudinal study of risk factors for community-based home help services in alzheimer's disease: The influence of cholinesterase inhibitor therapy

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 329-339

  Wattmo, Carina ^a   Paulsson, Elisabeth ^a   Minthon, Lennart ^a   Londos, Elisabet ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Activities of daily living; Cognition; Gender; Predictors; Treatment effect

Indexed keywords

DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EFFECTIVENESS; COMMUNITY CARE; DAILY LIFE ACTIVITY; DEMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRAIL ELDERLY; HOME CARE; HUMAN; INSTITUTIONALIZATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTICENTER STUDY; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; SPOUSE; TREATMENT DURATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; COGNITION; GENDER; PREDICTORS; TREATMENT EFFECT;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHI-SQUARE DISTRIBUTION; CHOLINESTERASE INHIBITORS; FEMALE; GALANTAMINE; HOME CARE SERVICES; HUMANS; INDANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENYLCARBAMATES; PIPERIDINES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84875360556     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S40087     Document Type: Article

References (37)

1. Ott A, Breteler MM, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970-973.
2. Reisberg B, Ferris SH, de Leon MJ, et al. The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. Prog Clin Biol Res. 1989;317:23-41.
3. Jönsson L, Eriksdotter Jönhagen M, Kilander L, et al. Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2006;21(5):449-459.
4. Lagergren M. The systems of care for frail elderly persons: the case of Sweden. Aging Clin Exp Res. 2002;14(4):252-257.
5. Wimo A. Demenssjukdomarnas Samhällskostnader och Antalet Dementa i Sverige 2005 [The Societal Costs of Dementia and the Number of Demented in Sweden 2005]. Stockholm: Socialstyrelsen (The National Board of Health and Welfare); 2007. Swedish.
6. Kadushin G. Home health care utilization: a review of the research for social work. Health Soc Work. 2004;29(3):219-244.
7. Philp I, McKee KJ, Meldrum P, et al. Community care for demented and non-demented elderly people: a comparison study of financial burden, service use, and unmet needs in family supporters. BMJ. 1995;310(6993):1503-1506.
8. Graessel E, Luttenberger K, Bleich S, Adabbo R, Donath C. Home nursing and home help for dementia patients: predictors for utilization and expected quality from a family caregiver's point of view. Arch Gerontol Geriatr. 2011;52(2):233-238.
9. Wimo A, Sjolund BM, Skoldunger A, Johansson L, Nordberg G, von Strauss E. Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons: results from a 3-year follow-up population-based study. Int J Geriatr Psychiatry. 2011;26(1):56-64.
10. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;1:CD005593.
11. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72(3):310-314.
12. Wattmo C, Wallin AK, Londos E, Minthon L. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. Gerontologist. 2011;51(1):17-27.
13. Mortimer JA, Ebbitt B, Jun SP, Finch MD. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology. 1992;42(9):1689-1696.
14. Wallin AK, Andreasen N, Eriksson S, et al. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. Dement Geriatr Cogn Disord. 2007;23(3):150-160.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
16. Frances A, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
18. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186.
19. International Classification of Functioning, Disability and Health (ICF). [webpage on the Internet]. Geneva: World Health Organization; 2001. Available from: http://www.who.int/classifications/icf/en/. Accessed September 21, 2012.
20. Kolada [webpage on the Internet]. Kommun- och landstingsdatabasen [The Swedish Municipal and County Database]. Stockholm: Rådet för Främjande av Kommunala Analyser (RKA); 2010. Available from: http://www.kolada.se/portal.php. Accessed September 21, 2012. Swedish.
21. Raskind MA, Peskind ER, Truyen L, Kershaw P, Damaraju CV. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. Arch Neurol. 2004;61(2):252-256.
22. Small GW, Kaufer D, Mendiondo MS, Quarg P, Spiegel R. Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years. Int J Clin Pract. 2005;59(4):473-477.
23. Winblad B, Wimo A, Engedal K, et al. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord. 2006;21(5-6):353-363.
24. Wattmo C, Wallin AK, Londos E, Minthon L. Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment. Alzheimer Dis Assoc Disord. 2011;25(1):63-72.
25. Geldmacher DS, Provenzano G, McRae T, Mastey V, Ieni JR. Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc. 2003;51(7):937-944.
26. Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004;363(9427):2105-2115.
27. Forbes DA, Jansen SL, Markle-Reid M, et al. Gender differences in use and availability of home and community-based services for people with dementia. Can J Nurs Res. Mar 2008;40(1):39-59.
28. Bass DM, Looman WJ, Ehrlich P. Predicting the volume of health and social services: integrating cognitive impairment into the modified Andersen framework. Gerontologist. 1992;32(1):33-43.
29. Doty P, Jackson ME, Crown W. The impact of female caregivers' employment status on patterns of formal and informal eldercare. Gerontologist. 1998;38(3):331-341.
30. Heyman A, Peterson B, Fillenbaum G, Pieper C. Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII. Neurology. 1997;48(5):1304-1309.
31. Hatoum HT, Thomas SK, Lin SJ, Lane R, Bullock R. Predicting time to nursing home placement based on activities of daily living scores - a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil. J Med Econ. 2009;12(2):98-103.
32. Hawranik P. The role of cognitive status in the use of inhome services: implications for nursing assessment. Can J Nurs Res. 1998;30(2):45-65.
33. Penning MJ. Cognitive impairment, caregiver burden, and the utilization of home health services. J Aging Health. 1995;7(2):233-253.
34. Johansson L, Sundstrom G, Hassing LB. State provision down, offspring's up: the reverse substitution of old-age care in Sweden. Ageing Soc. 2003;23(03):269-280.
35. Nordberg G, von Strauss E, Kareholt I, Johansson L, Wimo A. The amount of informal and formal care among non-demented and demented elderly persons-results from a Swedish population-based study. Int J Geriatr Psychiatry. 2005;20(9):862-871.
36. Wenger GC, Burholt V, Scott A. Dementia and help with household tasks: a comparison of cases and non-cases. Health Place. 1998;4(1):33-44.
37. Feldman HH, Van Baelen B, Kavanagh SM, Torfs KE. Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Dis Assoc Disord. 2005;19(1):29-36.